ATOS Stock: 9% Drop Mid-Day After Annual Forecast Revision
This Tuesday morning, the stock of the IT group is undergoing a significant correction at €51.69, marking a 9% loss since the opening compared to the previous day's close of €56.80. This downturn follows the release of the third-quarter 2025 results and the downward adjustment of revenue targets for the full year. Trading volume represents 1.47% of the capital, indicating sustained market activity.
Significant Decline Since Market Open
The stock has been markedly declining since the session opened, falling €5.11 from the previous day. This correction ranks ATOS among the steepest declines in the SBF 120, while the CAC 40 index shows a slight increase of 0.06% to 8,211.03 points at the same time. Over the past week, the stock still maintains a gain of 0.96%, and over three months, the performance remains largely positive with an increase of 87.96%. However, over one year, the stock has seen a decrease of 5.52%, a notable underperformance compared to the CAC 40's rise of 7.86% over the same period. The stock's volatility is recorded at 20.31 over one month, reflecting significant price movements in a context of profound transformation for the group. The current price of €51.69 places the stock above the identified support threshold of €44.61, but more than €9 below the resistance at €61.05. The capital turnover of 1.47% this Tuesday reflects marked trading activity in response to management announcements.
Third Quarter Results and Revised Forecasts
The third-quarter results published on October 20 revealed a revenue of €1.977 billion, a 10.5% organic decline compared to the same period in 2024. Over the first nine months of the year, the group has thus totaled €5.998 billion in revenue, representing an organic decrease of 15.2%. The traditional IT services division fell by nearly 18%, while the Eviden branch, focused on cloud and cybersecurity, grew by 77.1% in the third quarter, notably due to the Jupiter contract. Led by Philippe Salle, the group has revised its revenue forecast for 2025, now expected to exceed €8 billion, down from approximately €8.5 billion previously. This revision is due to the impact of exchange rates, the reduction in revenues from less profitable or loss-making contracts, and a generally unfavorable market environment. The book-to-bill ratio stands at 66% for the third quarter, stable year-on-year but considered insufficient: while it has improved by 9 points for the Atos division, it has dropped by 52 points for Eviden.
Technical Analysis
Technically, the stock is trading above its 50-day moving average, positioned at €47.44, and well above the 200-day moving average at €36.16. The RSI indicator shows a value of 49, close to the neutrality zone, while the MACD presents a negative signal with a line at 1.85 and a signal at 2.34, generating a histogram of -0.49. The Bollinger Bands frame the price between €46.93 and €61.31, placing the stock in the middle part of this channel. The Average True Range (ATR) of €1.61 suggests a relatively contained daily variation amplitude given the context, while the beta coefficient of 0.13 indicates limited sensitivity to overall market movements. The Chaikin Money Flow (CMF) displays a value of 0.00, signaling no significant buying or selling pressure on capital flows. The negative On-Balance Volume (OBV) at -3,993,338 indicates a net outflow of volumes over the recent period.
